Led by drug discovery experts in partnership with world-leading academic researchers, the Drug Discovery Alliance bridges the gap between discovery science taking place in universities across the UK and drug development expertise in pharmaceutical companies.

The Alzheimer’s Research UK Oxford Drug Discovery Institute (ODDI) couples the deep disease knowledge and biology expertise of the academic community with high quality, innovative drug discovery technologies, to accelerate the discovery of novel, effective therapeutics for Alzheimer's disease and other neurodegenerative diseases.

Dec 8, 2022 · Since its inception, the DDA has worked on over 60 projects, but the drug discovery landscape is constantly changing. ARUK’s latest five-year research strategy re-emphasises our commitment to finding life-changing treatments to bring hope to people living with dementia.

The ARUK Drug Discovery Alliance (DDA) with Cambridge and Oxford DDIs is the largest network of preclinical neuroscience drug discovery experts in the UK, maybe the world. The ARUK advisory board of industry experts provide expert input and keep us focused on the critical path to deliver medicines.

Jun 21, 2023 · The Drug Discovery Alliance is an ambitious initiative driven by UK DRI founding funder, Alzheimer’s Research UK (ARUK). It consists of three cutting-edge Institutes (DDIs), hosted at University College London, the University of …

Jun 15, 2017 · We are the Alzheimer’s Research Drug Discovery Institute at University College London! Follow us for news about our research and researchers. Come work with us!

Oct 31, 2022 · To support us in accelerating dementia drug discovery, ARUK is currently looking to recruit new members to join the ARUK-DDA Advisory Group (ADAG).

In addition, in 2015, the Drug Discovery Alliance (DDA) was launched by the Alzheimer's Research UK (ARUK), bringing together three institutes (University of Cambridge, University of Oxford, and University College London) with the aim of bridging the gap between discovery science and drug development.

The Drug Discovery Alliance is an ambitious multi-million dementia drug discovery initiative uniting three dedicated drug discovery institutes, all working to translate new findings from academic research into potential treatments for dementia.

Susan Kohlhaas, PhD, Alzheimer's Research UK, Cambridge, UK, talks on the major research gaps that Alzheimer’s Research UK (ARUK) is hoping to address.